RxDoctor Payments Data

Brooke Hall

Nurse Practitioner · Clay City, INNPI 1730665597

Payments from drug & device makers

$2,342in general payments, 2019–2025

Across 129 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$431
  • Novo Nordisk$385
  • AbbVie$346
  • GSK$240
  • Lilly USA, LLC$194
  • Bayer$179
  • plus $568 from 13 others

What the payments were for

  • Food & beverage$2,30298%
  • Education$402%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,342 in reported general payments places this provider in the 85th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol115$109,823
OzempicSemaglutide62$81,537
JardianceEmpagliflozin84$72,193
JanuviaSitagliptin Phosphate86$67,843
TrulicityDulaglutide16$23,040
XareltoRivaroxaban21$21,250
EliquisApixaban27$21,020
ViberziEluxadoline11$18,613
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,318
MounjaroTirzepatide11$11,381
Breo ElliptaFluticasone/Vilanterol23$10,724
LinzessLinaclotide14$9,298
Tresiba Flextouch U-100Insulin Degludec16$9,161
Combivent RespimatIpratropium/Albuterol Sulfate14$6,889
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$5,581

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$431$114,067130 claims
Novo NordiskOzempic$385$81,53762 claims
Boehringer IngelheimJardiance, Combivent Respimat$54$79,08198 claims
MerckJanuvia$12$67,84386 claims
Lilly USA, LLCTrulicity, Mounjaro$194$34,42127 claims
AbbVieViberzi, Linzess, Synthroid$346$29,26642 claims
GSKTrelegy Ellipta, Breo Ellipta$240$23,04234 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$1,776193 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Clay City

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →